— Know what they know.
Not Investment Advice
Also trades as: 0HD2.L (LSE) · $vol 0M · DUL.DE (XETRA) · $vol 0M

ALNY NASDAQ

Alnylam Pharmaceuticals, Inc.
1W: +2.4% 1M: -3.2% 3M: -10.6% YTD: -24.9% 1Y: +3.0% 3Y: +57.4% 5Y: +121.5%
$297.45
-3.06 (-1.02%)
 
Weekly Expected Move ±4.3%
$262 $275 $287 $299 $312
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 46 · $39.7B mcap · 133M float · 0.822% daily turnover · Short 46% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -92.8%
Cost Advantage
63
Intangibles
26
Switching Cost
69
Network Effect
80
Scale
37
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ALNY shows a Weak competitive edge (53.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -92.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$370
Low
$408
Avg Target
$447
High
Based on 2 analysts since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 39Hold: 12Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$408.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-01 Morgan Stanley $360 $370 +10 +22.7% $301.45
2026-05-01 Bernstein $451 $447 -4 +47.6% $302.85
2026-02-17 Canaccord Genuity $336 $429 +93 +36.5% $314.40
2026-02-13 Morgan Stanley $495 $360 -135 +14.7% $313.75
2026-02-13 Bernstein $491 $451 -40 +44.4% $312.43
2026-02-13 Chardan Capital $475 $425 -50 +37.8% $308.48
2026-02-12 Stifel Nicolaus Paul Matteis $508 $444 -64 +41.8% $313.05
2026-01-30 H.C. Wainwright $570 $510 -60 +47.1% $346.79
2026-01-20 RBC Capital $300 $465 +165 +29.5% $359.00
2026-01-20 Wells Fargo Initiated $376 +4.7% $359.00
2026-01-12 Needham Initiated $529 +32.8% $398.29
2026-01-12 Raymond James Martin Auster $370 $472 +102 +18.5% $398.29
2026-01-08 Truist Financial $535 $530 -5 +26.5% $419.07
2026-01-06 Bernstein $310 $491 +181 +26.7% $387.44
2025-12-15 Leerink Partners Mani Foroohar $96 $351 +255 -12.1% $399.42
2025-12-11 Stifel Nicolaus $495 $508 +13 +25.6% $404.46
2025-11-04 H.C. Wainwright Patrick Trucchio $400 $570 +170 +31.3% $434.07
2025-10-31 Barclays $210 $527 +317 +17.2% $449.56
2025-10-31 Oppenheimer Leland Gershell Initiated $500 +11.2% $449.56
2025-10-31 Chardan Capital Keay Nakae Initiated $475 +5.7% $449.56
2025-10-30 UBS $288 $549 +261 +22.1% $449.56
2025-10-30 Morgan Stanley Michael Ulz $475 $495 +20 +10.1% $449.56
2025-10-22 Cantor Fitzgerald $175 $450 +275 -5.1% $474.00
2025-10-17 Truist Financial $385 $535 +150 +11.6% $479.19
2025-10-06 Morgan Stanley Michael Ulz $250 $475 +225 +4.1% $456.35
2025-10-06 Stifel Nicolaus Paul Matteis $295 $495 +200 +8.5% $456.35
2025-09-05 BMO Capital Kostas Biliouris $360 $470 +110 +3.8% $452.81
2025-07-29 Raymond James Initiated $370 +11.9% $330.55
2025-07-21 Truist Financial Danielle Brill Initiated $385 +18.6% $324.49
2025-06-24 BMO Capital Kostas Biliouris $300 $360 +60 +10.8% $325.00
2025-03-21 Scotiabank Initiated $338 +19.3% $283.34
2025-01-07 Bernstein William Pickering Initiated $310 +31.4% $235.95
2024-10-24 Canaccord Genuity Whitney Ijem $366 $336 -30 +13.9% $294.87
2024-10-01 Canaccord Genuity Whitney Ijem $357 $366 +9 +33.7% $273.69
2024-09-27 Bank of America Securities Tazeen Ahmad $209 $307 +98 +11.7% $274.91
2024-08-27 BMO Capital Kostas Biliouris $234 $300 +66 +11.4% $269.31
2024-08-26 RBC Capital Luca Issi $265 $300 +35 +10.5% $271.43
2024-08-16 Goldman Sachs Salveen Richter $273 $370 +97 +40.8% $262.70
2024-07-08 Canaccord Genuity Whitney Ijem Initiated $357 +40.6% $253.86
2024-06-28 UBS Esther Rajavelu $211 $288 +77 +16.6% $247.00
2024-06-27 RBC Capital Luca Issi $250 $265 +15 +8.1% $245.17
2024-06-27 Stifel Nicolaus Paul Matteis $247 $295 +48 +19.2% $247.40
2024-06-25 Evercore ISI Liisa Bayko Initiated $260 +16.6% $222.90
2024-06-25 RBC Capital Luca Issi $235 $250 +15 +12.2% $222.90
2024-06-24 Morgan Stanley Andrew Galler $178 $250 +72 +11.3% $224.70
2024-06-24 H.C. Wainwright Patrick Trucchio $430 $400 -30 +76.2% $227.05
2024-06-24 Stifel Nicolaus Paul Matteis Initiated $247 +8.4% $227.92
2024-06-12 RBC Capital Luca Issi $225 $235 +10 +50.2% $156.43
2024-04-08 BMO Capital Kostas Biliouris $166 $234 +68 +49.4% $156.59
2022-12-15 Piper Sandler Edward Tenthoff $208 $253 +45 +10.3% $229.37

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ALNY receives an overall rating of B. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-12 B- B
2026-03-09 B B-
2026-03-04 B- B
2026-02-17 B B-
2026-02-13 C- B
2026-02-13 B- C-
2026-01-03 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

75 Grade A
Profitability
80
Balance Sheet
60
Earnings Quality
76
Growth
92
Value
31
Momentum
100
Safety
100
Cash Flow
62
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ALNY scores highest in Safety (100/100) and lowest in Value (31/100). An overall grade of A places ALNY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.55
Safe Zone
Piotroski F-Score
6/9
Beneish M-Score
-1.75
Possible Manipulator
Ohlson O-Score
-7.16
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A
Score: 73.9/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.24x
Accruals: -2.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ALNY scores 6.55, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ALNY scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ALNY's score of -1.75 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ALNY's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ALNY receives an estimated rating of A (score: 73.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ALNY's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
68.48x
PEG
0.03x
P/S
9.26x
P/B
36.76x
P/FCF
71.31x
P/OCF
64.15x
EV/EBITDA
71.88x
EV/Revenue
10.29x
EV/EBIT
77.06x
EV/FCF
68.77x
Earnings Yield
1.26%
FCF Yield
1.40%
Shareholder Yield
0.00%
Graham Number
$23.16
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 68.5x earnings, ALNY is priced for high growth expectations. Graham's intrinsic value formula yields $23.16 per share, 1184% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.984
NI / EBT
×
Interest Burden
1.025
EBT / EBIT
×
EBIT Margin
0.134
EBIT / Rev
×
Asset Turnover
0.931
Rev / Assets
×
Equity Multiplier
10.752
Assets / Equity
=
ROE
134.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ALNY's ROE of 134.8% is driven by financial leverage (equity multiplier: 10.75x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 0.98 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$35.50
Price/Value
9.32x
Margin of Safety
-832.16%
Premium
832.16%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ALNY's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ALNY trades at a 832% premium to its adjusted intrinsic value of $35.50, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 68.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$297.45
Median 1Y
$319.31
5th Pctile
$146.84
95th Pctile
$696.27
Ann. Volatility
45.5%
Analyst Target
$408.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Yvonne L. Greenstreet,
M.D. Chief Executive Officer (principal executive officer)
$1,404,200 $5,512,500 $14,867,600
Jeffrey V. Poulton
Executive Vice President, Chief Financial Officer (principal financial officer)
$724,400 $3,988,480 $6,863,800
Bryan A. Supran
Executive Vice President, Chief Legal Officer and Secretary
$190,400 $6,000,430 $6,846,350
Pushkal Garg, M.D.
Executive Vice President, Chief Research and Development Officer
$767,900 $3,687,650 $6,490,500
Tolga Tanguler President,
Vice President, Chief Commercial Officer
$698,000 $3,687,650 $6,129,020

CEO Pay Ratio

31:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,867,600
Avg Employee Cost (SGA/emp): $484,285
Employees: 2,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,500
+12.1% YoY
Revenue / Employee
$1,485,575
Rev: $3,713,937,000
Profit / Employee
$125,499
NI: $313,747,000
SGA / Employee
$484,285
Avg labor cost proxy
R&D / Employee
$529,792
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -72.2% -68.3% -1.1% -1.1% -1.2% -1.5% -5.3% -5.0% -4.9% -2.4% 2.3% 1.8% 38.5% 1.8% 3.6% 3.5% 4.2% -56.7% 73.3% 1.3% 1.35%
ROA -30.6% -28.9% -24.2% -25.3% -27.8% -33.5% -31.5% -29.6% -29.6% -14.2% -11.9% -9.0% -2.0% -9.0% -6.9% -6.7% -7.9% 1.1% 6.8% 12.5% 12.54%
ROIC 1.8% 1.7% 65.9% 62.2% 66.4% 73.5% 60.2% 60.4% 63.4% 27.2% 16.5% 10.3% -6.0% 11.0% -1.2% -78.6% -1.2% 1.8% -57.9% -92.8% -92.82%
ROCE -27.0% -24.8% -24.1% -25.1% -27.7% -34.5% -34.9% -33.0% -33.5% -13.8% -10.9% -6.9% 2.4% -6.5% -7.7% -6.9% -7.4% 4.3% 11.9% 16.4% 16.35%
Gross Margin 82.4% 82.6% 85.4% 83.3% 81.8% 84.4% 84.7% 82.8% 73.2% 88.8% 80.5% 86.7% 89.6% 82.9% 82.7% 88.0% 81.5% 84.2% 75.6% 81.9% 81.91%
Operating Margin -66.3% -96.8% -75.3% -68.8% -85.3% -97.6% -56.3% -46.9% -72.1% 28.5% -26.5% -8.8% 7.4% -15.4% -17.7% 3.0% -2.1% 29.5% 12.0% 23.0% 23.02%
Net Margin -85.9% -1.1% -100.0% -1.1% -1.2% -1.5% -61.9% -54.5% -86.6% 19.7% -31.4% -13.3% -2.6% -22.3% -14.1% -9.7% -8.6% 20.1% 17.0% 17.6% 17.65%
EBITDA Margin -64.9% -81.1% -82.0% -87.9% -98.7% -1.3% -48.6% -40.5% -72.5% 26.0% -21.1% -3.0% 5.6% -12.0% -23.8% 1.9% 2.4% 23.8% 13.2% 13.1% 13.05%
FCF Margin -95.0% -92.2% -85.0% -74.4% -74.6% -65.7% -59.1% -52.9% -43.7% -3.9% 2.3% 6.4% 13.6% 0.8% -1.9% -3.2% -2.1% 6.9% 12.5% 15.0% 14.96%
OCF Margin -86.0% -82.0% -76.0% -65.6% -65.4% -58.2% -52.2% -46.9% -38.2% 0.1% 5.7% 9.4% 15.9% 2.7% -0.4% -1.9% -0.6% 8.3% 14.1% 16.6% 16.63%
ROA 3Y Avg snapshot only -1.14%
ROIC Economic snapshot only 39.38%
Cash ROA snapshot only 14.35%
NOPAT Margin snapshot only 18.21%
Pretax Margin snapshot only 13.68%
R&D / Revenue snapshot only 33.11%
SGA / Revenue snapshot only 30.17%
SBC / Revenue snapshot only 6.77%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -22.52 -26.85 -23.82 -22.02 -17.98 -20.69 -25.90 -23.35 -22.26 -45.62 -54.61 -56.77 -422.21 -106.44 -108.78 -129.83 -132.52 1437.64 172.73 79.23 68.482
P/S Ratio 29.04 30.02 24.06 22.34 19.94 25.45 28.24 21.74 19.14 13.49 13.15 9.41 13.14 16.88 13.46 14.91 17.18 19.51 14.59 10.67 9.264
P/B Ratio 19.65 22.14 34.53 33.42 29.98 41.57 -185.14 -157.13 -149.65 -147.01 -108.97 -85.44 -139.57 -160.29 451.03 521.93 630.31 933.56 68.67 57.95 36.758
P/FCF -30.55 -32.56 -28.29 -30.05 -26.71 -38.71 -47.76 -41.12 -43.79 -349.43 573.22 147.48 96.58 2201.71 -710.48 -464.48 -811.82 282.93 116.45 71.31 71.312
P/OCF 11789.04 230.84 99.68 82.73 625.34 235.58 103.40 64.15 64.153
EV/EBITDA -25.95 -32.32 -28.53 -26.22 -20.93 -23.58 -30.67 -27.63 -25.99 -68.22 -88.71 -123.28 238.50 -261.52 -169.37 -229.68 -247.68 336.00 111.20 71.88 71.879
EV/Revenue 27.07 28.21 22.35 20.71 18.31 23.95 27.40 20.98 18.43 12.99 12.53 8.84 12.65 16.34 13.48 14.93 17.20 19.53 14.15 10.29 10.288
EV/EBIT -24.47 -30.17 -26.61 -24.64 -19.83 -22.62 -29.27 -26.15 -24.53 -58.44 -73.36 -89.83 429.62 -183.18 -128.68 -166.87 -186.22 480.97 126.04 77.06 77.060
EV/FCF -28.48 -30.60 -26.28 -27.85 -24.54 -36.43 -46.34 -39.68 -42.18 -336.33 546.18 138.61 93.02 2131.12 -711.63 -465.13 -812.76 283.15 112.94 68.77 68.770
Earnings Yield -4.4% -3.7% -4.2% -4.5% -5.6% -4.8% -3.9% -4.3% -4.5% -2.2% -1.8% -1.8% -0.2% -0.9% -0.9% -0.8% -0.8% 0.1% 0.6% 1.3% 1.26%
FCF Yield -3.3% -3.1% -3.5% -3.3% -3.7% -2.6% -2.1% -2.4% -2.3% -0.3% 0.2% 0.7% 1.0% 0.0% -0.1% -0.2% -0.1% 0.4% 0.9% 1.4% 1.40%
PEG Ratio snapshot only 0.029
Price/Tangible Book snapshot only 57.953
EV/OCF snapshot only 61.867
EV/Gross Profit snapshot only 12.718
Acquirers Multiple snapshot only 58.639
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $23.16
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 4.47 4.47 4.04 4.04 4.04 4.04 3.51 3.51 3.51 3.51 3.08 3.08 3.08 3.08 2.78 2.78 2.78 2.78 2.76 2.76 2.762
Quick Ratio 4.34 4.34 3.91 3.91 3.91 3.91 3.34 3.34 3.34 3.34 2.99 2.99 2.99 2.99 2.71 2.71 2.71 2.71 2.71 2.71 2.706
Debt/Equity 0.51 0.51 1.70 1.70 1.70 1.70 -8.34 -8.34 -8.34 -8.34 -5.92 -5.92 -5.92 -5.92 40.89 40.89 40.89 40.89 1.62 1.62 1.620
Net Debt/Equity -1.33 -1.33 -2.44 -2.44 -2.44 -2.44 0.73 0.73 0.73 0.73 -2.07 -2.07 -2.066
Debt/Assets 0.15 0.15 0.27 0.27 0.27 0.27 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.65 0.65 0.65 0.65 0.26 0.26 0.257
Debt/EBITDA -0.73 -0.80 -1.51 -1.44 -1.29 -1.02 -1.42 -1.52 -1.50 -4.02 -5.05 -9.08 10.50 -9.97 -15.33 -17.97 -16.05 14.71 2.70 2.08 2.083
Net Debt/EBITDA 1.89 2.07 2.17 2.07 1.86 1.47 0.94 1.00 0.99 2.66 4.39 7.89 -9.12 8.66 -0.27 -0.32 -0.29 0.26 -3.45 -2.66 -2.657
Interest Coverage -6.17 -5.20 -4.96 -4.84 -5.04 -6.25 -6.23 -6.44 -7.15 -3.20 -2.58 -1.55 0.53 -1.39 -1.66 -1.45 -1.49 0.80 1.65 2.02 2.020
Equity Multiplier 3.35 3.35 6.19 6.19 6.19 6.19 -22.41 -22.41 -22.41 -22.41 -17.36 -17.36 -17.36 -17.36 63.20 63.20 63.20 63.20 6.29 6.29 6.293
Cash Ratio snapshot only 1.983
Debt Service Coverage snapshot only 2.166
Cash to Debt snapshot only 2.275
FCF to Debt snapshot only 0.502
Defensive Interval snapshot only 495.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.24 0.26 0.24 0.25 0.25 0.27 0.29 0.32 0.34 0.48 0.50 0.54 0.64 0.57 0.56 0.58 0.61 0.80 0.81 0.93 0.931
Inventory Turnover 1.74 1.91 1.73 1.79 1.82 1.92 1.57 1.75 2.16 2.56 2.85 2.95 2.80 2.81 3.86 3.92 4.80 6.13 8.42 10.16 10.160
Receivables Turnover 9.46 10.31 5.61 5.85 5.88 6.39 4.75 5.24 5.67 7.90 6.46 7.08 8.29 7.41 6.13 6.41 6.72 8.76 6.28 7.25 7.248
Payables Turnover 2.25 2.46 2.24 2.31 2.34 2.48 1.97 2.19 2.71 3.22 4.04 4.19 3.97 3.99 4.49 4.56 5.60 7.14 6.65 8.02 8.024
DSO 39 35 65 62 62 57 77 70 64 46 56 52 44 49 60 57 54 42 58 50 50.4 days
DIO 209 191 210 204 201 190 233 209 169 142 128 124 131 130 95 93 76 60 43 36 35.9 days
DPO 162 148 163 158 156 147 185 166 135 113 90 87 92 91 81 80 65 51 55 45 45.5 days
Cash Conversion Cycle 86 79 112 108 107 100 124 112 99 75 94 88 83 88 73 70 65 50 47 41 40.8 days
Fixed Asset Turnover snapshot only 6.054
Operating Cycle snapshot only 86.3 days
Cash Velocity snapshot only 1.474
Capital Intensity snapshot only 1.158
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 99.2% 86.9% 71.3% 54.1% 28.6% 28.2% 22.9% 29.9% 39.9% 79.4% 76.2% 75.2% 89.5% 21.5% 23.0% 17.2% 5.0% 53.2% 65.2% 82.6% 82.57%
Net Income -4.8% 6.0% 0.6% -1.9% -10.6% -41.1% -32.6% -19.3% -8.4% 56.9% 61.1% 68.8% 93.1% 34.8% 36.8% 18.8% -3.4% 1.1% 2.1% 3.1% 3.14%
EPS -2.2% 8.4% 3.5% 0.9% -7.7% -37.6% -28.9% -15.7% -5.2% 59.9% 61.8% 69.3% 93.3% 33.4% 38.3% 21.0% -3.3% 1.1% 2.1% 3.0% 3.01%
FCF 25.0% 10.9% -4.8% 2.7% -1.0% 8.6% 14.6% 7.6% 18.1% 89.5% 1.1% 1.2% 1.6% 1.2% -2.0% -1.6% -1.2% 12.8% 11.9% 9.5% 9.51%
EBITDA 9.8% 19.7% 10.2% 3.0% -7.9% -49.2% -40.1% -25.0% -13.4% 66.4% 72.1% 83.4% 1.1% 60.1% 30.7% -6.2% -2.4% 2.4% 3.6% 5.0% 5.02%
Op. Income 18.6% 24.0% 14.5% 16.8% 4.9% -11.7% -10.8% -17.8% -15.6% 55.2% 64.1% 77.7% 1.1% 46.9% 37.3% 34.4% -2.8% 2.4% 3.8% 7.5% 7.52%
OCF Growth snapshot only 16.80%
Asset Growth snapshot only 17.13%
Equity Growth snapshot only 10.76%
Debt Growth snapshot only -53.40%
Shares Change snapshot only 6.59%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 86.0% 1.0% 1.2% 1.2% 1.1% 78.4% 67.8% 58.7% 53.0% 62.6% 54.8% 52.0% 50.5% 40.9% 38.6% 38.7% 40.7% 49.5% 53.0% 55.3% 55.35%
Revenue 5Y 87.2% 82.3% 78.1% 71.8% 68.0% 69.1% 63.1% 65.2% 63.2% 79.8% 89.5% 87.6% 87.5% 65.4% 59.2% 52.4% 48.1% 51.6% 49.8% 49.7% 49.66%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 75.0% 89.5% 1.1% 1.1% 1.0% 73.4% 64.6% 56.2% 50.5% 63.1% 54.1% 52.4% 52.7% 42.1% 39.8% 40.0% 40.8% 49.6% 51.7% 53.7% 53.68%
Gross Profit 5Y 80.5% 75.7% 71.7% 65.7% 62.0% 63.3% 57.4% 59.4% 56.6% 73.7% 83.4% 83.4% 86.0% 63.2% 58.1% 51.8% 47.5% 51.9% 48.9% 48.8% 48.82%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 19.5% 19.5% 32.3% 32.3% 32.3% 32.3% 14.0% 14.0% 14.0% 14.0% 4.0% 4.0% 4.0% 4.0% 5.2% 5.2% 5.2% 5.2% 11.9% 11.9% 11.88%
Assets 5Y 19.7% 19.7% 23.6% 23.6% 23.6% 23.6% 12.2% 12.2% 12.2% 12.2% 19.5% 19.5% 19.5% 19.5% 12.1% 12.1% 12.1% 12.1% 7.8% 7.8% 7.83%
Equity 3Y -16.8% -16.8% -23.3% -23.3% -23.3% -23.3% -51.5% -51.5% -51.5% -51.5%
Book Value 3Y -21.1% -21.3% -27.5% -26.6% -26.0% -26.2% -52.6% -52.7% -52.6% -53.4%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.73 0.78 0.80 0.83 0.86 0.90 0.92 0.95 0.96 0.89 0.92 0.92 0.87 0.95 0.95 0.95 0.92 0.93 0.90 0.86 0.857
Earnings Stability 0.90 0.86 0.79 0.81 0.86 0.86 0.79 0.80 0.84 0.00 0.04 0.15 0.22 0.33 0.46 0.53 0.44 0.69 0.72 0.75 0.751
Margin Stability 0.91 0.91 0.92 0.92 0.92 0.92 0.92 0.92 0.91 0.92 0.93 0.95 0.96 0.96 0.97 0.98 0.97 0.99 0.98 0.98 0.978
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Earnings Persistence 0.98 0.98 1.00 0.99 0.96 0.84 0.87 0.92 0.97 0.50 0.50 0.50 0.50 0.86 0.85 0.92 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness
ROE Trend -0.25 -0.20 -0.72 -0.78 -0.94 -1.29
Gross Margin Trend -0.05 -0.04 -0.03 -0.02 -0.01 0.01 -0.00 0.00 -0.02 0.00 -0.01 0.00 0.05 0.01 0.02 0.02 -0.00 -0.01 -0.03 -0.04 -0.041
FCF Margin Trend 2.05 1.14 0.80 0.64 0.99 0.77 0.53 0.43 0.41 0.75 0.74 0.70 0.73 0.36 0.27 0.20 0.13 0.08 0.12 0.13 0.134
Sustainable Growth Rate 73.3% 1.3% 1.35%
Internal Growth Rate 1.1% 7.3% 14.3% 14.34%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.67 0.73 0.75 0.65 0.59 0.47 0.48 0.50 0.44 -0.00 -0.24 -0.57 -5.10 -0.17 0.03 0.17 0.05 6.10 1.67 1.24 1.235
FCF/OCF 1.11 1.12 1.12 1.13 1.14 1.13 1.13 1.13 1.14 -33.74 0.40 0.68 0.86 0.28 5.12 1.67 3.35 0.83 0.89 0.90 0.900
FCF/Net Income snapshot only 1.111
OCF/EBITDA snapshot only 1.162
CapEx/Revenue 9.1% 10.2% 9.0% 8.8% 9.3% 7.5% 6.9% 6.0% 5.5% 4.0% 3.4% 3.1% 2.3% 1.9% 1.5% 1.3% 1.5% 1.4% 1.6% 1.7% 1.67%
CapEx/Depreciation snapshot only 1.735
Accruals Ratio -0.10 -0.08 -0.06 -0.09 -0.11 -0.18 -0.16 -0.15 -0.16 -0.14 -0.15 -0.14 -0.12 -0.11 -0.07 -0.06 -0.08 -0.06 -0.05 -0.03 -0.029
Sloan Accruals snapshot only 0.094
Cash Flow Adequacy snapshot only 9.962
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -0.9% -1.0% -1.2% -1.2% -0.9% -1.0% -0.9% -1.1% -1.3% -0.7% -0.6% -0.7% -0.7% -0.8% -1.0% -0.9% -0.7% -0.1% -0.1% -0.0% -0.01%
Total Shareholder Return -0.9% -1.0% -1.2% -1.2% -0.9% -1.0% -0.9% -1.1% -1.3% -0.7% -0.6% -0.7% -0.7% -0.8% -1.0% -0.9% -0.7% -0.1% -0.1% -0.0% -0.01%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.02 1.02 1.18 1.03 0.74 0.76 0.84 -1.36 0.97 0.98 0.984
Interest Burden (EBT/EBIT) 1.16 1.19 1.20 1.21 1.20 1.16 1.16 1.16 1.14 1.31 1.39 1.65 -0.89 1.72 1.60 1.69 1.67 -0.25 0.77 1.02 1.025
EBIT Margin -1.11 -0.94 -0.84 -0.84 -0.92 -1.06 -0.94 -0.80 -0.75 -0.22 -0.17 -0.10 0.03 -0.09 -0.10 -0.09 -0.09 0.04 0.11 0.13 0.134
Asset Turnover 0.24 0.26 0.24 0.25 0.25 0.27 0.29 0.32 0.34 0.48 0.50 0.54 0.64 0.57 0.56 0.58 0.61 0.80 0.81 0.93 0.931
Equity Multiplier 2.36 2.36 4.39 4.39 4.39 4.39 16.72 16.72 16.72 16.72 -19.47 -19.47 -19.47 -19.47 -52.55 -52.55 -52.55 -52.55 10.75 10.75 10.752
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-7.53 $-7.03 $-7.12 $-7.42 $-8.11 $-9.68 $-9.18 $-8.58 $-8.53 $-3.88 $-3.50 $-2.63 $-0.58 $-2.58 $-2.16 $-2.08 $-2.46 $0.32 $2.30 $4.18 $4.18
Book Value/Share $8.63 $8.53 $4.91 $4.89 $4.87 $4.81 $-1.28 $-1.27 $-1.27 $-1.20 $-1.76 $-1.75 $-1.74 $-1.72 $0.52 $0.52 $0.52 $0.49 $5.79 $5.71 $8.09
Tangible Book/Share $8.63 $8.53 $4.91 $4.89 $4.87 $4.81 $-1.28 $-1.27 $-1.27 $-1.20 $-1.76 $-1.75 $-1.74 $-1.72 $0.52 $0.52 $0.52 $0.49 $5.79 $5.71 $5.71
Revenue/Share $5.84 $6.29 $7.05 $7.31 $7.31 $7.87 $8.42 $9.21 $9.93 $13.12 $14.55 $15.88 $18.50 $16.29 $17.48 $18.11 $18.99 $23.37 $27.25 $31.01 $32.26
FCF/Share $-5.55 $-5.80 $-6.00 $-5.43 $-5.46 $-5.17 $-4.98 $-4.87 $-4.34 $-0.51 $0.33 $1.01 $2.52 $0.12 $-0.33 $-0.58 $-0.40 $1.61 $3.41 $4.64 $4.83
OCF/Share $-5.02 $-5.16 $-5.36 $-4.79 $-4.78 $-4.58 $-4.39 $-4.32 $-3.79 $0.02 $0.83 $1.50 $2.94 $0.44 $-0.06 $-0.35 $-0.12 $1.94 $3.85 $5.16 $5.36
Cash/Share $15.92 $15.73 $20.33 $20.23 $20.15 $19.94 $17.79 $17.66 $17.59 $16.69 $19.42 $19.34 $19.25 $18.97 $20.95 $20.78 $20.78 $19.62 $21.34 $21.04 $22.64
EBITDA/Share $-6.09 $-5.49 $-5.52 $-5.77 $-6.40 $-7.99 $-7.52 $-7.00 $-7.04 $-2.50 $-2.06 $-1.14 $0.98 $-1.02 $-1.39 $-1.18 $-1.32 $1.36 $3.47 $4.44 $4.44
Debt/Share $4.43 $4.37 $8.33 $8.29 $8.25 $8.17 $10.71 $10.64 $10.59 $10.05 $10.39 $10.35 $10.30 $10.15 $21.33 $21.16 $21.16 $19.97 $9.38 $9.25 $9.25
Net Debt/Share $-11.49 $-11.36 $-12.01 $-11.94 $-11.89 $-11.77 $-7.08 $-7.03 $-7.00 $-6.64 $-9.03 $-8.99 $-8.95 $-8.82 $0.38 $0.38 $0.38 $0.36 $-11.96 $-11.79 $-11.79
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.548
Altman Z-Prime snapshot only 11.285
Piotroski F-Score 5 4 4 5 3 4 2 2 2 5 5 6 6 6 5 5 2 7 6 6 6
Beneish M-Score 3.77 5.88 -2.85 -3.29 -3.56 -3.60 -2.98 -2.82 -2.89 -1.89 -2.73 -2.69 -2.38 -2.34 -2.19 -2.14 -2.20 -1.41 -1.84 -1.75 -1.746
Ohlson O-Score snapshot only -7.160
ROIC (Greenblatt) snapshot only 17.38%
Net-Net WC snapshot only $-0.92
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A
Credit Score 51.78 58.17 40.77 42.18 36.59 48.04 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 45.52 53.53 55.97 51.65 73.03 73.95 73.948
Credit Grade snapshot only 6
Credit Trend snapshot only 20.413
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 75
Sector Credit Rank snapshot only 69

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms